guanidinoacetic acid Report issue

Small molecule Experimental
AACT MeSH PubChem

Active Ingredient History

NOW
  • Now
Glycocyamine is a metabolite of glycine in which the amino group has been converted into a guanidine by guanylation. In vertebrate organism it is then transformed into creatine by methylation.   Wikipedia

Chemistry

  • SMILES: NC(=N)NCC(O)=O
  • InChIKey: BPMFZUMJYQTVII-UHFFFAOYSA-N
  • Mol. Mass: 117.1066
  • ALogP: Missing data
  • ChEMBL Molecules: Missing data
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

glycine, n-(aminoiminomethyl)- | glycocyamine | glycocyamine, 2-(14)c-labeled | glycocyamine, ion (1-) | glycocyamine monohydrochloride | guanidinoacetate | guanidinoacetic acid | guanidoacetic acid | n-amidinoglycine

Organizations (4)

Research & Development (4)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (2)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (2)


 

Athletic Performance (Phase 1/Phase 2)

Hyperhomocysteinemia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial Organizations: 4

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue